Pharmacists in Maryland - Medicare Status, Address, Contact

5791 Pharmacists found. Showing 81 - 100

Christie Dunton, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy Ste G10, Annapolis, MD 21401 Phone: 443-481-5826

Binal Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 Main St, Annapolis, MD 21401 Phone: 410-295-3061

Riyo Rajan, PHARMD Pharmacist - Oncology Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4157

Jazzmine C Miller Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 Riva Rd, Annapolis, MD 21401 Phone: 410-571-2090    Fax: 410-571-2896

Margaret M Thomas, PHARM.D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4229    Fax: 443-481-4842

Matthew Howard Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Bay Ridge Rd, Annapolis, MD 21403 Phone: 443-268-7688    Fax: 410-268-4597

Abdul Rehman Khan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 609 Taylor Ave, Annapolis, MD 21401 Phone: 410-268-5007

Mr. Tho Vu Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2027 West St, Annapolis, MD 21401 Phone: 410-266-5055

Dr. Chad Richard Blaszczyk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 Riva Rd, Annapolis, MD 21401 Phone: 814-440-1563

Dr. Audrey Z. Hathaway, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2002 Medical Pkwy Ste 170, Annapolis, MD 21401 Phone: 410-573-6900    Fax: 410-573-1127

Brittney Edwards Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Bay Ridge Road Bridge Shopping Center, Annapolis, MD 21403 Phone: 410-268-7688

Samuel Brackett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Chinquapin Round Rd, Annapolis, MD 21401 Phone: 438-370-2004

Dr. Craig Eugene Long, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 709 S Cherry Grove Ave, Apt. 103, Annapolis, MD 21401 Phone: 301-639-9937

Mrs. Bariat Sotayo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Generals Hwy, Annapolis, MD 21401 Phone: 410-224-7669

Michael C. Roberts, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 703 Giddings Ave, Suitew L-1, Annapolis, MD 21401 Phone: 410-263-7440    Fax: 410-269-5947

Andrew Munoz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 703 Giddings Ave Ste L1, Annapolis, MD 21401 Phone: 410-263-7440    Fax: 410-269-5947

Jennifer Ann Liberatore Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 Riding Ridge Rd, Annapolis, MD 21403 Phone: 410-991-7080

Kyle Lewandowski, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2027 West St Ste B, Annapolis, MD 21401 Phone: 410-266-5055

Dr. Kyle Hochreiter Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 503 South Cherry Grove Ave, Annapolis, MD 21401 Phone: 443-482-3981

Oluwashogo Reuben Buremoh, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 Riva Rd, Annapolis, MD 21401 Phone: 410-571-2090

News Archive

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

A new study published on the preprint server medRxiv* presents an analysis of the differences between recorded vaccination side effects vs. early COVID-19 symptoms. The researchers focused on four vaccines, namely, Pfizer-BioNTech (PB) mRNA (BNT162b2) vaccine, based on messenger ribonucleic acid encoding the viral spike protein; the Moderna mRNA (mRNA-1273) vaccine; the Oxford-AstraZeneca (O-AZ) adenovirus-vectored vaccine; and the Janssen adenovirus-vectored Ad26.COV2.S).

NASP, SmartBrief partner to launch first news brief dedicated to specialty pharmacy industry

The National Association of Specialty Pharmacy and SmartBrief recently partnered to deliver a daily newsletter providing the specialty pharmacy industry with a snapshot of the top news in the industry.

Pharmacy directors willing to cover tanezumab at lower prices

HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.

UH environmental engineer to test parts of Galveston Bay for dioxins and PCBs

A University of Houston environmental engineer will test parts of Galveston Bay for toxic chemicals in an effort to help state officials determine the best way to handle those pollutants.

Anadys Pharmaceuticals' ANA598 combination demonstrates 73% cEVR in ongoing Phase II study for HCV

Anadys Pharmaceuticals, Inc. today announced preliminary results from an ongoing Phase II study demonstrating that 73% of hepatitis C patients treated with 200 mg ANA598 twice daily in combination with pegylated interferon and ribavirin (SOC) achieved undetectable levels of virus (<15 IU/mL) at week 12, known as complete Early Virological Response or cEVR.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4
• 5(current)
• 6
• 7
• 8
• 9
• 10
• 11
• »